FDA Inspection 820229 — OPMX, LLC

OPMX, LLC — FEI 3008937007

The FDA completed an inspection of OPMX, LLC on February 20, 2013 in Chula Vista, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 9 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 20, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Chula Vista, CA (United States)

Citations

IDCFRDescription
1540121 CFR 111.12(b)Personnel - quality control operations; identified
1564221 CFR 111.455(a)Hold - temperature, humidity, light
1579721 CFR 111.553Written procedures - product complaint
1592721 CFR 111.103Written procedures - quality control operations
1604221 CFR 111.503Written procedures - returned dietary supplement
241921 CFR 211.198(a)Complaint Handling Procedure
433621 CFR 211.150Written distribution procedure
433821 CFR 211.150(b)Recall facilitation
434221 CFR 211.142(b)Storage under appropriate conditions